Diefenbach K, Trummer D, Ebert F, Lissy M, Koch M, Rohde B, & Blode H. (2013). EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: Folate status during 24 weeks of treatment and over 20 weeks following treatment cessation. Dove Medical Press.
Chicago Style (17th ed.) CitationDiefenbach K, Trummer D, Ebert F, Lissy M, Koch M, Rohde B, and Blode H. EE-drospirenone-levomefolate Calcium Versus EE-drospirenone + Folic Acid: Folate Status During 24 Weeks of Treatment and over 20 Weeks Following Treatment Cessation. Dove Medical Press, 2013.
MLA (9th ed.) CitationDiefenbach K, et al. EE-drospirenone-levomefolate Calcium Versus EE-drospirenone + Folic Acid: Folate Status During 24 Weeks of Treatment and over 20 Weeks Following Treatment Cessation. Dove Medical Press, 2013.